Sotera Health (NASDAQ:SHC) Receives Average Rating of "Moderate Buy" from Analysts

Sotera Health (NASDAQ:SHC - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six analysts that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $15.92.

A number of equities research analysts have issued reports on the stock. Barclays cut their target price on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating for the company in a research report on Friday, February 28th. The Goldman Sachs Group started coverage on Sotera Health in a report on Friday, December 6th. They set a "neutral" rating and a $14.00 price objective for the company.

Institutional Investors Weigh In On Sotera Health

A number of large investors have recently added to or reduced their stakes in SHC. Geode Capital Management LLC grew its stake in shares of Sotera Health by 19.4% in the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock worth $46,026,000 after acquiring an additional 447,186 shares during the last quarter. Maven Securities LTD acquired a new stake in Sotera Health in the 3rd quarter worth $1,670,000. Cerity Partners LLC acquired a new position in shares of Sotera Health during the third quarter valued at about $1,489,000. Neo Ivy Capital Management acquired a new position in shares of Sotera Health during the third quarter valued at about $720,000. Finally, Barclays PLC lifted its stake in shares of Sotera Health by 169.8% in the third quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after buying an additional 298,085 shares during the period. Institutional investors own 91.03% of the company's stock.

Remove Ads

Sotera Health Stock Down 0.6 %

NASDAQ SHC traded down $0.07 during trading on Wednesday, reaching $11.90. 1,623,348 shares of the company's stock were exchanged, compared to its average volume of 1,167,244. The firm has a market capitalization of $3.37 billion, a PE ratio of 47.60 and a beta of 1.92. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.08. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The company's fifty day simple moving average is $12.94 and its 200-day simple moving average is $14.15.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.